Massive 10,000-Patient stent registry launches across 15 countries
NCT ID NCT05505929
Summary
This registry study aims to collect real-world safety and performance data on the BioFreedom coronary stent system after it has been approved for market use. Researchers will follow 10,000 patients across up to 150 medical centers in multiple countries for one year after their stent procedure. The study observes how the stent performs in everyday clinical practice rather than testing a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST MARKET CLINICAL FOLLOW UP (PMCF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Al Qassimi Hospital
RECRUITINGSharjah city, United Arab Emirates
Contact
-
Clinique Des Domes Psr
RECRUITINGClermont-Ferrand, France
Contact
-
Golden Jubilee National Hospital
RECRUITINGGlasgow, United Kingdom
Contact
-
Hospital Marques Valdecilla
RECRUITINGSantander, Spain
Contact
-
Klinikum Lippe
RECRUITINGDetmold, Germany
Contact
-
Krankenhaus Barmherzige Brüder
RECRUITINGEisenstadt, Austria
Contact
-
Military hospital
RECRUITINGTunis, Tunisia
Contact
-
Royal Bournemouth hospital
RECRUITINGBournemouth, United Kingdom
Contact
-
University and Hospital Fribourg
RECRUITINGFribourg, Switzerland
Contact
-
Universitäres Herzzentrum
RECRUITINGZurich, Switzerland
Contact
Conditions
Explore the condition pages connected to this study.